Skip to content
To the full analysis

GSK stock: balance sheet and debt

GSK
$50.64Closing price of 12 Nov 2026MEQIRI Score 69 out of 100

GSK has a debt to equity ratio of 1.11 and an interest coverage of 12.2x.

Daily figure as of 13 Nov 2026

Debt / Equity
1.11
Interest coverage
12.2x
Current ratio
0.82
Cash & equivalents
$4.51B
Total assets
$80.87B
Equity ratio
26.1%
Goodwill
$9.29B
Plus intangible assets of $22.16B
Net debt
$18.94B

Total assets and equity ratio

How large the balance sheet of GSK plc is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$33.87B$5.37B$1B37.8%$3.25B
2007$41.1B$7.72B$1.82B32.0%$7.37B
2008$52.22B$10.56B$2.78B21.1%$12.35B
2009$56.82B$15.3B$4.46B25.1%$12.35B
2010$55.74B$16.01B$4.78B23.2%$11.62B
2011$54.45B$15.32B$4.98B21.5%$11.93B
2012$54.98B$19.25B$5.78B16.3%$18.61B
2013$55.79B$17.88B$5.57B18.6%$16.76B
2014$53.89B$15.97B$4.94B12.1%$19.06B
2015$70.85B$28.94B$6.84B16.6%$14.06B
2016$78.32B$32.8B$7.91B8.4%$18.05B
2017$74.74B$30.88B$7.6B6.2%$17.38B
2018$76.97B$30.48B$7.67B6.3%$29.3B
2019$139.94B$72.91B$18.55B23.0%$45.17B
2020$145.74B$73.24B$19.2B25.9%$37.65B
2021$142.02B$72.95B$18.95B27.0%$35.62B
2022$79.73B$28.32B$9.34B16.8%$17.38B
2023$75.22B$27.51B$8.68B21.7%$16.36B
2024$78.82B$29.82B$9.26B22.0%$17.59B
2025$80.87B$31.45B$9.29B26.1%$18.94B

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$4.03B$12.44B$7.28B0.57
2007$6.64B$12.73B$14.01B1.07
2008$9.11B$10.51B$21.46B1.95
2009$9.2B$13.26B$21.55B1.51
2010$8.4B$11.78B$20.02B1.55
2011$7.82B$10.65B$19.75B1.69
2012$5.65B$7.7B$24.26B2.71
2013$7.42B$9.27B$24.18B2.34
2014$5.84B$5.65B$24.9B3.81
2015$7.99B$6.78B$22.05B1.87
2016$6.86B$1.49B$24.91B3.79
2017$5.27B−$90.14M$22.65B4.9
2018$5.25B$5.01B$34.55B7.1
2019$8.4B$20.03B$53.57B1.66
2020$11.54B$26.43B$49.2B1.3
2021$7.78B$27.03B$43.4B1.13
2022$10.44B$14.05B$27.82B2.08
2023$6.61B$17.01B$22.97B1.41
2024$4.92B$18.12B$22.52B1.3
2025$4.51B$21.67B$23.45B1.11

Debt to equity divides debt by total equity, including non-controlling interests, as S&P calculates it. The equity column shows the part that belongs to shareholders.

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = £0.7544)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral since 13 Nov 2026, previously Strong
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy